Drug intelligence / Profile preview

St. John's wort extract Ze 117

Development stage
Phase 4
Lead developer
Max Zeller Söhne
Modality
Small Molecules
Administration
Oral
01

Overview

St. John's wort extract Ze 117 is a standardized dry herbal extract derived from the aerial parts of Hypericum perforatum L., commonly known as St. John’s wort. It is used primarily for the treatment of mild to moderate depressive episodes and has demonstrated non-inferiority to standard antidepressants in clinical studies[2][4]. The mechanism of action involves inhibition of presynaptic reuptake of serotonin, dopamine, and noradrenaline (norepinephrine), resulting in increased synaptic concentrations of these neurotransmitters[2][4][5]. Additionally, chronic exposure leads to downregulation of beta-adrenoceptors similar to tricyclic antidepressants[4]. Unlike many other St. John’s wort extracts, Ze 117 contains low levels of hyperforin (≤1%), which minimizes drug-drug interaction risk by reducing induction effects on cytochrome P450 enzymes and P-glycoprotein transporters[2][6]. The extraction solvent is ethanol (57.9% V/V), with a drug-extract ratio (DER) between 4-7:1[2].

Brand names
RemotivRemotiv 250Remotiv250Remotiv-250Remotiv 500Remotiv500Remotiv-500
Other names
Hypericum perforatum extract Ze 117St. John's wort dry extract Ze 117
02

Targets

SERT (Sodium-dependent serotonin transporter)NET (Norepinephrine Transporter)

Beyond the preview

Go deeper on St. John's wort extract Ze 117.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on St. John's wort extract Ze 117.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call